Lv1
50 积分 2025-10-13 加入
Genetically engineered Salmonella, SGN1, as a tumor microenvironment-targeting modality capable of methionine reduction for oral squamous cell carcinoma
2天前
已关闭
CHO细胞外源抗体基因拷贝数实时定量PCR检测方法的建立及验证
11天前
已完结
Targeting the Tumor Microenvironment in Triple-Negative Breast Cancer: Biological Insights and Therapeutic Opportunities
2个月前
已完结
Development of a live and highly attenuated Listeria monocytogenes-based vaccine for the treatment of Her2/neu-overexpressing cancers in human
2个月前
已完结
Engineering oncolytic bacteria as precision cancer therapeutics: design principles, therapeutic strategies, and translational perspectives
3个月前
已关闭
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
4个月前
已完结
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
4个月前
已完结
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
4个月前
已完结
皖公网安备34019202002308
